Fungal infections are on the rise, driven by a growing population at risk and climate change.
Currently available antifungals include only five classes, and their utility and efficacy in …

Despite improvements in treatment and diagnostics over the last two decades, invasive
aspergillosis (IA) remains a devastating fungal disease. The number of …

Fungal infections represent a serious global health problem, causing damage to health and
the economy on the scale of millions. Although vaccines are the most effective therapeutic …

Introduction Fungal infections are caused by a broad range of pathogenic fungi that are
found worldwide with different geographic distributions, incidences, and mortality rates …

Aspergillus fumigatus is an opportunistic pathogen that infects immunocompromised
patients and imposes a heavy burden on global health. Searching for key genes in host …

Fungal infections are incurring high risks in a range from superficial mucosal discomforts
(such as oropharyngeal candidiasis and vulvovaginal candidiasis) to disseminated life …

Invasive fungal infections are a leading cause of death in immunocompromised patients.
Current therapies have several limitations, and innovative antifungal agents are critically …

Human fungal infections (mycoses) cause significant morbidity and mortality in high-risk
populations. Contemporary antifungal therapies rely heavily on three classes of antifungal …

Sterylglucosides (SGs) are sterol conjugates widely distributed in nature. Although their
universal presence in all living organisms suggests the importance of this kind of glycolipids …